Literature DB >> 25588989

Use of medication algorithms in first episode psychosis: a naturalistic observational study.

Rafal A H Yeisen1, Inge Joa2,3, Jan Olav Johannessen2,3, Stein Opjordsmoen2,4,5.   

Abstract

AIMS: Medical algorithms are evidence-based guidelines which help physicians to make their decisions regarding treatment. Non-adherence to medical algorithms is a matter of concern. The aims of this study were to investigate physicians' adherence to an algorithm for antipsychotics, patients' adherence to the physicians' recommendations and whether these factors influence one year outcome.
METHOD: An extensive file audit survey was conducted among 55 consecutively first admitted inpatients and outpatients from three units of a university hospital; looking at the prescription of antipsychotics to patients (15-65 years) experiencing first episode psychosis (F19.5, F20.0-F29.0 according to ICD-10). Inclusion period was 2 years. Data on clinical condition and use of drugs were collected from the electronic patient administrative record system and from each patient's medical record for 12 months.
RESULTS: Only 62% of the physicians adhered to the medical algorithm, although all first choices of drugs were made according to international standards. Fifty-six percent of patients used their medicine more than 75% of the time, 22% had between 26% and 74% adherence and 22% adhered less than 25%. Patient adherence was significantly associated with good outcome. Older patients and inpatients had more favourable outcomes than younger patients and outpatients. Physicians at inpatient wards initiated pharmacological treatment significantly earlier than physicians in outpatient departments. The most common first antipsychotic drug to prescribe was olanzapine followed by risperidone.
CONCLUSION: Initial medical intervention followed international standards, but the physicians failed to adhere to algorithms in their follow-up of medication regimes. Adherence was associated with outcome.
© 2015 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  adherence; algorithm; antipsychotics; early intervention; outcome

Mesh:

Substances:

Year:  2015        PMID: 25588989     DOI: 10.1111/eip.12203

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  5 in total

1.  Experiences of antipsychotic use in patients with early psychosis: a two-year follow-up study.

Authors:  Rafal A H Yeisen; Jone Bjornestad; Inge Joa; Jan Olav Johannessen; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2017-08-22       Impact factor: 3.630

Review 2.  Improving access to specialized care for first-episode psychosis: an ecological model.

Authors:  Aubrey M Moe; Ellen B Rubinstein; Colin J Gallagher; David M Weiss; Amanda Stewart; Nicholas Jk Breitborde
Journal:  Risk Manag Healthc Policy       Date:  2018-08-30

3.  Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study.

Authors:  Dolores Keating; Stephen McWilliams; Fiona Boland; Roisin Doyle; Caragh Behan; Judith Strawbridge; Mary Clarke
Journal:  BMJ Open       Date:  2021-01-31       Impact factor: 2.692

4.  One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.

Authors:  Petros Drosos; Kolbjørn Brønnick; Inge Joa; Jan Olav Johannessen; Erik Johnsen; Rune Andreas Kroken; Helen Joy Stain; Wenche Ten Velden Hegelstad; Tor Ketil Larsen
Journal:  J Clin Psychopharmacol       Date:  2020 Nov/Dec       Impact factor: 3.118

5.  Pharmacological treatment algorithms for the acute phase, agitation, and maintenance phase of first-episode schizophrenia: Japanese Society of Clinical Neuropsychopharmacology treatment algorithms.

Authors:  Hiroyoshi Takeuchi; Yoshiteru Takekita; Hikaru Hori; Kazuto Oya; Itaru Miura; Naoki Hashimoto; Norio Yasui-Furukori
Journal:  Hum Psychopharmacol       Date:  2021-07-09       Impact factor: 1.672

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.